| Stakk Limited (SKK) ORDINARY FULLY PAID |
Information Technology |
$72 |
Stakk achieves record monthly revenue in October
|
5 Nov 2025 9:52AM |
$0.053 |
$0.023 |
fallen by
56.60%
|
|
SKK - Price-sensitive ASX Announcement
Full Release
Key Points
- Stakk Limited achieved a record monthly revenue of $575k in October.
- Revenue increased by 146% month-over-month and 9,467% year-over-year.
- Growth attributed to organic development and new client acquisitions.
- The company is well-positioned for future growth with a strong cash position.
- The announcement was approved by Stakk Ltd's Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FBR Ltd (FBR) ORDINARY FULLY PAID |
Industrials |
$28 |
FBR executes MOU for Hadrian unit sale
|
5 Nov 2025 9:52AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
FBR - Price-sensitive ASX Announcement
Full Release
Key Points
- FBR Limited has executed a non-binding Memorandum of Understanding with Fraser Lyne Constructions Pty Ltd for the sale of a Hadrian unit.
- The initial purchase order for one Hadrian unit is valued at A$7.8 million, subject to finalization of specifications.
- A deposit of A$780,000 is required within 14 days of the definitive agreement execution.
- The remainder of the purchase price is due within 30 days of successful completion of Factory Acceptance Testing.
- The agreement includes a minimum 12-month warranty and training for Fraser Lyne personnel.
- FBR will provide remote IT support and access to ancillary software, including TAD.
- Fraser Lyne is a construction company based in New South Wales, dealing with residential construction.
- The agreement aims to address the housing crisis on the Mid North Coast of New South Wales.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,821 |
Notification regarding unquoted securities - SUL
|
5 Nov 2025 9:51AM |
$15.820 |
$12.490 |
fallen by
21.05%
|
|
| ARC Funds Limited (ARC) ORDINARY FULLY PAID |
Financials |
$5 |
ARC Funds Limited Strategic Investment in Ausbiz TV Pty Ltd
|
5 Nov 2025 9:51AM |
$0.100 |
$0.071 |
fallen by
29%
|
|
ARC - Price-sensitive ASX Announcement
Full Release
Key Points
- ARC Funds Limited (ASX:ARC) announced a strategic purchase of convertible notes in AUSBIZ TV PTY LTD.
- The convertible notes have a face value of $2.15 million, with ARC acquiring them for 20% of the face value.
- ARC will issue new shares to vendors at $0.105 per share, totaling $430K in new shares.
- Consideration Shares issued will total 4,467,404 new shares.
- The investment aligns with ARC's objective to diversify investment opportunities and grow its business.
- Ausbiz Group provides live financial news with over 130,000 subscribers.
- ARC expects the investment to yield $215k additional income annually.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$299 |
Change to Solvar Board of Directors
|
5 Nov 2025 9:50AM |
$1.570 |
$1.585 |
risen by
0.96%
|
|
| Impact Minerals Limited (IPT) ORDINARY FULLY PAID |
Materials |
$26 |
Broken Hill Reborn
|
5 Nov 2025 9:48AM |
$0.006 |
$0.050 |
risen by
733.33%
|
|
IPT - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration activities resumed at Broken Hill project due to increased metal prices.
- Focus on high-grade nickel-copper-PGM sulphides and Broken Hill-style silver-lead-zinc mineralization.
- Significant results from Platinum Springs, part of the Moorkai Trend.
- Development of a proprietary multi-metal ratio for real-time targeting of high-grade zones.
- Discovery of consistent zones of higher-grade mineralisation after decades.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stavely Minerals Limited (SVY) ORDINARY FULLY PAID |
Materials |
$10 |
Strong Soil Auger Results Pave Way for Imminent RC Drilling
|
5 Nov 2025 9:47AM |
$0.018 |
$0.015 |
fallen by
19.44%
|
|
SVY - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong soil auger results indicate a second zone of gold mineralisation at Fairview South.
- Reconnaissance mapping and rock-chip sampling extended the prospect 600m south.
- High gold assay results from rock-chip samples, with one reaching 25.60g/t.
- Positive previous RC drilling results, including 40m at 1.96g/t gold from surface.
- Imminent Phase 3 RC drilling program planned to test southern extension.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$5 |
Exclusive Agreement to Develop Male Performance Product
|
5 Nov 2025 9:47AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH Global Ltd (ASX: BP8) entered an exclusive dealing agreement with scientist Jo-an Refugio.
- The agreement focuses on a ginseng-based formulation for male vitality and performance.
- BP8 has a six-month exclusive period for due diligence and product testing.
- The agreement allows BP8 to negotiate for acquisition of intellectual property rights.
- A non-refundable exclusivity fee of AUD 9,000 is payable to Jo-an.
- The formulation is based on Traditional Chinese Medicine principles.
- The product aims to support male vitality through healthy circulation and energy balance.
- BPH Global is exploring both OTC wellness products and clinically tested evidence-based products.
- Further product development may include Jo-an as an R&D consultant.
- The announcement was authorized by the Board of Directors of BPH Global Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alliance Nickel Limited (AXN) ORDINARY FULLY PAID |
Materials |
$27 |
Trading Halt
|
5 Nov 2025 9:46AM |
$0.047 |
$0.035 |
fallen by
25.53%
|
|
AXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Alliance Nickel Limited (ASX: AXN) requested a trading halt.
- The halt is pending an announcement related to an offtake agreement with Stellantis N.V.
- The trading halt is expected not to exceed the commencement of trading on 7 November 2025.
- Alliance is not aware of any reason why the trading halt should not be granted.
- The announcement was authorized for release by the Company Secretary of Alliance Nickel Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$9,864 |
LNW Update on Company Secretary
|
5 Nov 2025 9:46AM |
$116.000 |
$121.500 |
risen by
4.74%
|
|
| Peel Mining Limited (PEX) ORDINARY FULLY PAID |
Materials |
$134 |
Investor Presentation - November 2025
|
5 Nov 2025 9:45AM |
$0.100 |
$0.155 |
risen by
55%
|
|
PEX - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade polymetallic VMS system in Southern Nights Complex.
- Potential for zinc, lead, copper concentrates, plus gold and silver production.
- Preliminary mine design and metallurgical testwork completed.
- Environmental approvals and baseline studies are well advanced.
- 2,276km2 of 100%-owned tenure with five major deposits.
- Extensive drilling and fieldwork planned for FY2026.
- Ongoing business development and M&A activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$98 |
ALA Exercises Option for Baylor College of Medicine Assets
|
5 Nov 2025 9:45AM |
$0.089 |
$0.081 |
fallen by
8.99%
|
|
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$47 |
Change of Director's Interest Notice
|
5 Nov 2025 9:45AM |
$0.360 |
$0.335 |
fallen by
6.94%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,730 |
Statement of CDIs on issue - NWS
|
5 Nov 2025 9:42AM |
$45.760 |
$41.630 |
fallen by
9.03%
|
|
| 360 Capital Group (TGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$59 |
Change in substantial holding
|
5 Nov 2025 9:42AM |
$0.310 |
$0.300 |
fallen by
3.23%
|
|
| Wisr Limited (WZR) ORDINARY FULLY PAID |
Financials |
$32 |
Trading Halt
|
5 Nov 2025 9:42AM |
$0.034 |
$0.018 |
fallen by
47.06%
|
|
WZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Wisr Limited requested a trading halt due to a proposed capital raising.
- Trading halt to last until 7 November 2025 or release of an announcement.
- Request made under ASX Listing Rule 17.1.
- Proposed capital raising is material to Wisr Limited.
- No other information required for market about the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sarama Resources Ltd (SRR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$14 |
Statement of CDIs on issue - SRR
|
5 Nov 2025 9:42AM |
$0.040 |
$0.038 |
fallen by
5%
|
|
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$15 |
ReNerve Clinical Study Expansion
|
5 Nov 2025 9:42AM |
$0.096 |
$0.105 |
risen by
9.37%
|
|
RNV - Price-sensitive ASX Announcement
Full Release
Key Points
- Expansion of clinical study for NervAlign® Nerve Cuff.
- Study includes comparison between standard care and NervAlign® Nerve Cuff.
- Expected completion of patient recruitment by mid-2026.
- Study will support European market approval filing.
- ReNerve advancing a portfolio of nerve repair products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$205 |
Austral Resources Reinstated to Trading on ASX
|
5 Nov 2025 9:41AM |
$0.160 |
$0.082 |
fallen by
48.75%
|
|
AR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Austral Resources reinstated to ASX trading on 5 November 2025.
- $40 million Placement completed at $0.05 per share.
- Funds to strengthen balance sheet and Rocklands acquisition.
- Targeting 50,000 tonnes per annum copper production over 20 years.
- Dual-hub copper platform with Mount Kelly and Rocklands Plants.
- Recapitalised balance sheet and refreshed Board.
- Pro-forma enterprise value of around $85 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ENRG Elements Ltd (EEL) ORDINARY FULLY PAID |
Materials |
- |
Security Class Reinstatement to Quotation - EELO
|
5 Nov 2025 9:40AM |
$0.001 |
$0.002 |
risen by
50%
|
|
EEL - Price-sensitive ASX Announcement
Full Release
Key Points
- ENRG Elements Ltd's securities will be reinstated to quotation.
- The reinstatement follows compliance with ASX Listing Rule 2.5.
- The security class code for ENRG Elements Ltd is EELO.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Transition Minerals Ltd (ETM) ORDINARY FULLY PAID |
Materials |
$152 |
Appointment of Danish Advisors to Advisory Board
|
5 Nov 2025 9:40AM |
$0.081 |
$0.069 |
fallen by
14.81%
|
|
ETM - Price-sensitive ASX Announcement
Full Release
Key Points
- Former Danish Minister for Foreign Affairs, Mr. Jeppe Kofod, and former Danish Ambassador to the United States, Mr. Friis Arne Petersen, were appointed to ETM’s Advisory Board.
- The Advisory Board will provide strategic advice on ETM’s mineral development activities in Greenland, focusing on the Kvanefjeld Rare Earths Project.
- Mr. Kofod has extensive experience in foreign affairs, European policy, and sustainable development.
- Mr. Petersen has held senior diplomatic positions, including Danish Ambassador to the United States, China, and Germany.
- ETM's strategy includes transparency, responsibility, and alignment with international standards.
- Further appointments to the Advisory Board are expected, including representation from the United States.
- ETM Managing Director, Daniel Mamadou, emphasized the importance of these appointments for strategic dialogue with stakeholders and community trust-building.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$15 |
Quarterly Investor Webinar
|
5 Nov 2025 9:39AM |
$0.096 |
$0.105 |
risen by
9.37%
|
|
| Artrya Limited (AYA) ORDINARY FULLY PAID |
Health Care |
$655 |
Mass General Brigham to Participate in SAPPHIRE Study
|
5 Nov 2025 9:38AM |
$3.410 |
$4.100 |
risen by
20.23%
|
|
AYA - Price-sensitive ASX Announcement
Full Release
Key Points
- Mass General Brigham to participate in SAPPHIRE Study.
- SAPPHIRE Study scheduled to launch in early 2026.
- Study to evaluate Artrya's Salix® Plaque Analysis for coronary artery disease.
- Dr. Ron Blankstein appointed as Principal Investigator.
- Artrya aims to improve patient risk identification for cardiovascular events.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
- |
Proposed issue of securities - TYP
|
5 Nov 2025 9:38AM |
$0.038 |
$0.034 |
fallen by
10.53%
|
|
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
- |
Proposed issue of securities - TYP
|
5 Nov 2025 9:38AM |
$0.038 |
$0.034 |
fallen by
10.53%
|
|
Call 1300 880 160
Start a chat
Schedule a call
